Prof. Dr. Esin ÜNLÜ

Gastroenteroloji

Prof. Dr. Esin ÜNLÜ

Deneyim

ÖZEL ÇAMLIK TIP MERKEZİ

İç Hastalıkları Uzmanı/ Gastroenteroloji Bölümü
2019 - Halen, İstanbul/Türkiye

ÖZEL AVCILAR HASTANESİ

İç Hastalıkları Uzmanı/Gastroenteroloji Bölümü
2019 - Halen, İstanbul/Türkiye

CUMHURİYET ÜNİVERSİTESİ TIP FAKÜLTESİ

İç Hastalıkları Uzmanı/Gastroenteroloji Bölümü
2004 - 2016, İstanbul/Türkiye

19 MAYIS ÜNİVERSİTESİ TIP FAKÜLTESİ

İç Hastalıkları Uzmanı/Gastroenteroloji Bölümü
1994 - 2004 , İstanbul/Türkiye

HACETTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ

İç Hastalıkları Uzmanı/Gastroenteroloji Bölümü
1991 - 1993 , İstanbul/Türkiye

HACETTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ

İç Hastalıkları Uzmanı
1987 - 1991 , İstanbul/Türkiye

HACETTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ

Acil Tıp
1979 - 1985 , İstanbul/Türkiye

 

Eğitim

CUMHURİYET ÜNİVERSİTESİ TIP FAKÜLTESİ

Gastroenteroloji Profesörlük

2004, Sivas/Türkiye

19 MAYIS ÜNİVERSİTESİ TIP FAKÜLTESİ

Gastroenteroloji /Doçentlik
1994, Samsun/Türkiye

HACETTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ

Gastroenteroloji/Yan Dal Uzmanlığı

1991 – 1993, İstanbul/Türkiye

 

HACETTEPE ÜNİVERSİTESİ TIP FAKÜLTESİ

İç Hastalıkları Uzmanlığı

1987 – 1991,İstanbul/Türkiye

 

Katıldığı Mesleki Eğitimler, Kurslar ve Konferanslar

  • 50’nin üzerinde kongre seminer ve toplantılara katılım

 

Mesleki Üyelikleri

  • Türk Gastroenteroloji Derneği
  • Türk Tabipler Birliği

 

Bilimsel Yayınları

  • Tokgözoğlu L, Ünlü E, Özerkan K, Bayraktar Y, Telatar H, The Association Between Familial Mediterranean Fever and HLA Groups in Turkish Patients. Hacettepe Medical Journal 1989; 22: 275-280.
  • Tokgözoğlu L, Ünlü E, Bayraktar Y, Kayhan B, Telatar H .Familial Mediterranenan Fever; A Survey of Clinical Parameters of 58 Patients Compared with the Literature. Hacettepe Medical Journal 1989; 22: 267-273.
  • Özyılkan Ö, Ünlü E, Tekuzman G, Ruacan Ş, Baltalı E, Güler N, Güllü H.İ, Barışta İ, Özışık Y, Fırat D. Superior Vena Cava Syndrome : A 15 Year Period Experience. Kanser, The Turkish Journal of Cancer 1991; 21 : 189-115.
  • Özyılkan (Ünlü) E, Şimşek H, Telatar H. Tumor Necrosis Factor in Familial Mediterranean Fever’ The American Journal of Medicine 1992; 92: 579-580.
  • Özyılkan (Ünlü) E, Şimşek H, Özdemir O,. Sivri B, Kirazlı Ş, Telatar H. Plasminogen Activator Inhibitor-2 and Alpha-Fetoprotein in Various Liver Disease States. Thrombosis and Haemostasis 1992; 68: 374.
  • Özyılkan Ö, Ünlü E, Tekuzman G, Ş. Ruacan , Baltalı E, Fırat D. Superior Vena Cava Syndrome: Experience at the Hacettepe Medical Center Annals of Saudi Medicine 1992; 12: 587-588.
  • Özyılkan Ö, Baltalı E , Özyılkan (Ünlü) E, Tekuzman G, Kars A, Fırat D. Ceruloplasmin Level in Women with Breast Disease : Preliminary Results. Acta Oncologica 1992; 843-846.
  • Özyılkan (Ünlü) E, Köseoğlu T, Tatar G, Kayhan B, Telatar H. Cholelithiasis in Cirrhotic Patients from Turkey. The American Journal of Gastroenterology 1993; 88: 155-156.
  • Özyılkan (Ünlü) E, Tatar G, Köseoğlu T,  Kayhan B,  Telatar H. Hepatitis C Virus Infection in Chronic Hepatitis B Virus Carriers. European Journal of Medicine. 1993; 2: 188.
  • E. Özyılkan (Ünlü) E, Tatar G, Köseoğlu T, Telatar H. Prevalence of Antibodies to Hepatitis -C Virus among Turkish Patients with Chronic Liver Disease. Journal of Internal Medicine 1993; 233; 303-304.
  • Özyılkan (Ünlü) E, Şimşek H, Telatar H. Tumor Necrosis Factor in Familial Mediterranean Fever. European Journal of Internal Medicine 1993; 4: 227-231.
  • Topeli A, Özyılkan O, Özyılkan (Ünlü) E, Kars A, Fırat D. Prevalence of Hepatitis C, B and D Markers in Cancer in Cancer Patients in Turkey. European Journal of Clinical Microbiology & Infectious Diseases 1994; 13 : 38-40.
  • Özyılkan (Ünlü) E, Tatar G, Hacıbektaşoğlu A, Kayhan B, Telatar H. Analysis of T Helper and T Supressor Lymphocyte Subsets in Patients with Chronic hepatitis C Virus Infection. Journal of Internal Medicine 1993; 234: 436-437.
  • Özyılkan (Ünlü) E, Özyılkan Ö, Korkmaz M.E , Karaağaoğlu E, Ahmed A, Gürlek A, Moğultekin N, Kadayıfçı A. Prediction of Patient Mortality in a Medical Intensive Care Unit . Marmara Medical Journal 1993; 6: 10-15.
  • Özyılkan (Ünlü) E, Tatar G, Kayhan B, Telatar H. HLA Antigens in Liver Diseases due to Hepatitis C Virus. Doğa-Turkish Journal of Medical Sciences 1993; 17: 325-326.
  • Özyılkan Ö, Özyılkan (Ünlü) E, Kars A, Karaağaoğlu E, Tatar G, Tekuzman G, Baltalı E, Fırat D. Evaluation of Prognostic Factors with Respect to Survival of Colorectal Cancer Patients. Turkish Journal of Cancer 1993; 23 : 59-67
  • Özyılkan (Ünlü) E, Tatar G, Köseoğlu T, Telatar H. Prevalence of HBV Surface Antigen, Anti-HDV, and Anti-HCV Antibodies in Patients with Virus-Related Chronic Liver Disease. Microbiology Bulletin 1993, 27: 308-313.
  • Özyılkan (Ünlü) E, Tatar G, Hacıbektaşoğlu A , Kayhan B, Telatar H. Impaired Lipopolysaccharide-Induced Interleukin-1-Beta Production in Patients with Anti-HCV Antibody Positive Chronic Liver Disease. Scandinavian Journal of Gastroenterology 1994; 29: 280-283.
  • Özyılkan (Ünlü) E, Tatar G, Köseoğlu T, Telatar H. Serum Antibodies to Hepatitis C Virus in Turkish Patients with Chronic Liver Diseases. Annals of Saudi Medicine 1994;14:71-72.
  • Özyılkan (Ünlü) E, Şimşek H, TelataR H Absence of Asthma in Patients with Familial Mediterranean Fever. Israel Journal of Medical Sciences 1994;30:237-238.
  • Özyılkan (Ünlü) E, Erbaş T, Şimşek H, Telatar F, Kayhan B, Telatar H. Increased Prevalence of Hepatitis C Virus Antibodies in Patients with Diabetes Mellitus. Journal of Internal Medicine 1994; 235; 283-284.
  • Arat-Altındağ Z, Şahin G,  Özyılkan (Ünlü) E, Işımer A, Telatar H. Urinary Neopterin Level ın Familial Mediterranean Fever. La Press Medicale 1994; 23: 718.
  • Özyılkan (Ünlü) E, Özyılkan Ö, Telatar H, Fırat D. Hepatitis Virus Markers in Turkish Patients with Hepatocellular Carcinoma. Cancer 1994; 73 : 2002-2003.
  • Özyılkan (Ünlü) E, Köseoğlu T, Telatar H. Absence of Seasonal Fluctuations in Peptic Ulcer Activity. American Journal of Gastroenterology 1994; 89: 955-956.
  • Özyılkan (Ünlü) E, Akpolat T, Arık N, Köseoğlu T, Telatar H. Characteristicis of Chronic Hepatitis C Virus Infection in Patients on Maintenance Haemodialysis. Nephrology Dialysis and Transplantation 1994; 9: 1697-1698.
  • Özyılkan (Ünlü) E, Şimşek H, Uzunalimoğlu B, Telatar H , Interferon Treatment of Chronic Active Hepatitis C in Patients with End-stage Renal Disease. Nephron 1995; 71: 156-160.
  • Akpolat T, Özyılkan (Ünlü) E, Arık N. Eradication of Hepatitis C Virus after Interferon-alpha Therapy. Annals of Internal Medicine 1995; 122: 474. 
  • Şimşek H, Özyılkan (Ünlü) E, Köseoğlu T, Telatar H, Endoscopic Ligation of Esophagial Varices: Effectiveness and Complications. Doga-Turkish Journal of Medical Sciences 1995; 25: 61-64.
  • Özdamar SO, Özyılkan (Ünlü) E, Özyılkan Ö, Kandemir B. The Correlation Cell Nuclear Antigen Expressions in Colorectal Adenocarcinoma. Pathology International 1995; 45: 973-974.
  • Özyılkan Ö, Aslan M, Özyılkan (Ünlü) E. Hepatitis B Virus and Hepatitis C Virus Infection in Turkish Patients with Hepatocellular Carcinoma. American Journal of Gastroenterology 1996; 7: 1479-1488.
  • Özyılkan (Ünlü) E, Arslan M. Increased Prevalence of Diabetes Mellitus in Patients with Chronic Hepatitis C Virus Infection. American Journal of Gastroenerology 1996;7:1480-1481.
  • Cengiz K, Özyılkan (Ünlü) E, Coşar AM, Günaydın M. Seroprevalence of Hepatitis  E in Hemodialysis Patients in Turkey. Nephron 1996, 74:730
  • Özyılkan (Ünlü) E, Kahraman H, Onar M, Kesim G, Arık Z. Evoked Potentials and the Effect of Flumazenil in Patients with Liver Cirrhosis. East African Medical Journal 1997, 74:210-212.
  • Günaydın M, Bedir A, Akpolat T, Kuku I, Pekbay A, Sesen S, Özyılkan (Ünlü) E, Arık N, Cengiz K. Prevalence of Serum HGV-RNA Among Hemodialysis Patients in Turkey. Infection 1997, 25:307-309.
  • Akpolat I, Özyılkan (Ünlü) E, Karagöz F,  Kandemir B. Histopathological Characteristics of Chronic Hepatitis C Virus Infection in Turkey . Acta Gastroenterologica Belgica 1997, 60:251-254.
  • Taşkın V, Özyılkan (Ünlü) E, Hilmioğlu F. Needle Knife Papillotomy:Evaluation and Safety. East African Medical Journal 1998;75:471-474
  • Taşkın V, Özyılkan (Ünlü) E, Sare M, Hilmioğlu F. The effect of dividing the sphincter of Oddi at endoscopic sphincterotomy on the filling and emptying aspects of function of the gallbladder. Surg Laparosc Endoc Percutan Tech 1999, 9(5): 322 – 326
  • Taskın V, Gurer I, Özyılkan (Ünlü) E, Sare M, Hilmioğlu F. Effect of Helicobacter Pylori Eradication on peptic Ulcer Disease Complicated with Outlet Obstruction. Helicobacter 2000;5:38-40   
  • Taşkın V, Ortapamuk H, Özyılkan (Ünlü) E, Çetin F, Eskioğlu E, Köseoğlu T, Naldöken S. Does Omeprazole Alter the Salivary Gland Functions .Turkish Journal of Gastroenterology 2001; 12:113-116
  • Taşkın V, Özyılkan (Ünlü) E, Aydın A, Çetin F, Eskioğlu E, Köseoğlu T. Can Resistant Helicobacter Pylori İnfection be Estimated Histologically: Effects of Gastric Histology on Eradication Rates of Helicobacter Pylori Infection. Turkish Journal of Gastroenterology 2001; 12:126-129
  • Yilmaz A, Gursoy S, Varol O,Nur N, Özyılkan (Ünlü) E. Emergency Room Cases of Mushroom Poisoning. Saudi Medical Journal 2006 Jun; 27(6):858-61
  • Olgu sunumları
  • Özyılkan Ö , Baltalı E, Ruacan, Ünlü E, Korkmaz M.E, Kansu E, Fırat D. Richter’s Syndrome: A Case Report. Kanser, The Turkish Journal of Cancer 1991; 21: 120-1124.
  • Tatar G, Özyılkan (Ünlü) E, Telatar H. Blue Rubber Bleb Nevus syndrome: Report of A Case. Turkish Journal of Pediatrics 1993; 35: 131-134. 
  • Demirkan F, Akalın H, Şimşek H, Özyılkan (Ünlü) E, Telatar H. Spontaneous Peritonitis due to Brucella Mellitensis in a Patient with Cirrhosis. European Journal of Clinical Microbiology & Infectious Diseases 1993; 12: 66-67.
  • Sungur C, Özyılkan (Ünlü) E, Akpolat T, Yasavul U, Turgan C, Çağlar S. Relaps of Minimal Change Disease Associated with Alpha-Interferon Therapy. Nephron 1993;65:648.
  • Özyılkan (Ünlü) E, Tatar G , Gököz A, Telatar H .Carcinoid Tumor of the Anorectum: A Case report. Turkish Journal of Cancer 1993, 23203-208.
  • Arslan M, Özyılkan (Ünlü) E, Kayhan B , Telatar H. Familial Mediterranean Fever Associated with Lyphadenopathy. Doga-Turkish Journal of Medical Sciences 1994; 2: 283.
  • Arslan M, Özyılkan (Ünlü) E, Kayhan B, Telatar H. Raynaud’s Phenomenon Associated with Alpha-Interferon Therapy Journal of Internal Medicine 1994; 235; 503.
  • Özyılkan O, Özyılkan (Ünlü) E, Karagöz F, Özdamar S, Kandemir B. Hepatitis C Virus Infection and Angioimmunoblastic Lymphadenopathy. American Journal of Gastroenterology 1995, 98: 1829-1830.
  • Haznedaroğlu Ş, Özyılkan (Ünlü) E, Karaaslan Y. Hepatitis A : A Potentially Serious Disease. Annals of Internal Medicine 1998;129:506
  • Özyılkan O, Özyılkan (Ünlü) E. Gastric Hodgkin’s Disease Presenting with Radiologic Appearance of Linitis Plastica. American Journal of Gastroenterology 1999;94:3661-3362
  • Karaaslan Y, Haznedaroğlu S, Özyılkan (Ünlü)  E, Kaftan O. Granulocytopenia due to nifuroxazide followed by a G-CSF-induced Leukemoid Reaction. The Annals of Pharmacotherapy 1999;33:1229-1230
  • Bilgin G. Yılmaz A.S, Köksal E, Gülhan E , Akbulut S, Ergul G, Özyılkan (Ünlü) E. Primary Chest Hodgkin's Disease Diagnosed by Pleural Biopsy: Case Report. East African Medical Journal 2001, 78(7): 389 – 391
  • Çakmakcı A, Yılmaz A.S, Akbulut S, Gül U, Özyılkan (Ünlü) E. Polycythemia in a Patient Treated with Isotretinoin. Ann Pharmacother 2001, 35 (7-8) 964-965
  • Finci S, Akbulut S , Özyılkan (Ünlü) E. Primary Squamous Cell Carcinoma of the Stomach: a Case Report. Acta Gastroenterologica Belgica. 2003 Apr-Jun;66(2):18
  • Koruk ST, Özyılkan (Ünlü) E, Kaya P, Colak D, Donderici O, Cesaretli Y. Juniper tar poisoning. Clinical Toxicology (Phila) 2005; 43(1): 47-9